World

Women with PMOS should get subsidised weight-loss drugs, Australian advocates say

The Guardian World · 10 October 2026 at 00:00

Women with PMOS should get subsidised weight-loss drugs, Australian advocates say

With GLP-1s to treat the condition not specifically approved by the TGA, patients are being prescribed them off-label Get our breaking news email , free app or daily news podcast Women living with a chronic hormonal condition should have access to taxpayer-funded weight loss medications, advocates say.

The Polyendrocrine Metabolic Ovarian Syndrome Association of Australia (POSAA) is urging for GLP-1 drugs to be approved on the Pharmaceutical Benefits Scheme for people living with the condition.

Read the full article on The Guardian World ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.theguardian.com — the content belongs to The Guardian World.

Women with PMOS should get subsidised weight-loss drugs, Australian advocates say

More from The Guardian World

Powerful 7.6-magnitude earthquake hits Panama and triggers tsunami warnings

Controversial vaccine trial touted by RFK Jr gets go-ahead in Guinea-Bissau

Three men found guilty of murders of Australian surfer brothers and US friend in Mexico

ICJ judge Navi Pillay wins Nobel peace prize for promoting international law

More in World

Kash Patel wants to bring in UFC trainers to teach FBI agents hand-to-hand combat: report

Judge orders to Kennedy Center to turn over financial records as DOJ fights to keep Trump’s role secret

Powerful 7.6-magnitude earthquake hits Panama and triggers tsunami warnings

A botched execution and plans for one in public show the US is conflicted about capital punishment

Teen McDonald’s employee killed after 16-year-old coworker attacked him, cops say

Hurricane Isaias heads towards Gulf Coast as houses evacuated amid flood and power outage warnings